Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Shanghai MicroPort Endovascular MedTech Co., Ltd.
Sector
Healthcare
Industry
Medical - Devices
Employees
826
First IPO Date
July 22, 2019
Key Executives
| Name | Title | Pay | Year Born |
| Qing Zhu | GM & Director | 0 | 1981 |
| Chun Fang Li | Accounting Supervisor & Chief Financial Officer | 0 | 1980 |
| Liwen Wang | Core Technical Staff | 0 | 1982 |
| Zhenyu Yuan | Deputy GM, Core Technical Personnel & Employee Representative Director | 0 | 1977 |
| Ke Chen | Senior Director | 0 | 1980 |
| Lantao Guo | Deputy GM & Core Technical Personnel | 0 | 1966 |
| Hongjie Lu | Core Technical Staff | 0 | 1983 |
AD
Description
Established in Shanghai, PRC, in 2012, Shanghai MicroPort Endovascular MedTech Co., Ltd. specializes in the creation, production, and distribution of medical technologies and products, primarily addressing aortic and peripheral diseases. The company's key offerings include TAA and AAA stent graft systems, as well as different types of balloon catheters such as inflation and PTA dilatation catheters. It operates as a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd.
AD
